Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Torres KA et al. Activity of the aqueous extract of Schinus terebinthifolius Raddi on strains of the Candida genus. 2016 Rev Bras Ginecol Obstet pmid:28038478
Szwarc K et al. Intramolecular transformation of an antifungal antibiotic nystatin A into its isomer, iso-nystatin A - structural and molecular modeling studies. 2016 Magn Reson Chem pmid:27379602
Zemljič Jokhadar Š et al. Osmotic Effects Induced by Pore-Forming Agent Nystatin: From Lipid Vesicles to the Cell. 2016 PLoS ONE pmid:27788169
Diaz MC et al. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin]. 2016 Rev Esp Quimioter pmid:27167765
Lyu X et al. Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis. 2016 Drug Des Devel Ther pmid:27042008
Salyer AC et al. Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen. 2016 PLoS ONE pmid:26919709
Clark RS et al. Validation of research trajectory 1 of an Exposome framework: Exposure to benzo(a)pyrene confers enhanced susceptibility to bacterial infection. 2016 Environ. Res. pmid:26765097
Konecna A et al. ERG6 gene deletion modifies Kluyveromyces lactis susceptibility to various growth inhibitors. 2016 Yeast pmid:27668979
Pemberton MN Nystatin and miconazole: pharmacological and clinical evidence regarding interactions with warfarin. 2016 Oral Dis pmid:27416928
Falcone M et al. Management of candidemia in patients with Clostridium difficile infection. 2016 Expert Rev Anti Infect Ther pmid:27254270
Serrano-Mollar A et al. Safety and Tolerability of Alveolar Type II Cell Transplantation in Idiopathic Pulmonary Fibrosis. 2016 Chest pmid:27020420
Fabio CA et al. Use of photodynamic therapy and chitosan for inactivacion of Candida albicans in a murine model. 2016 J. Oral Pathol. Med. pmid:26991463
Preissner S et al. Adjuvant antifungal therapy using tissue tolerable plasma on oral mucosa and removable dentures in oral candidiasis patients: a randomised double-blinded split-mouth pilot study. 2016 Mycoses pmid:26932256
Vega F et al. Concomitant sensitization to inhaled budesonide and oral nystatin presenting as allergic contact stomatitis and systemic allergic contact dermatitis. 2016 Cutis pmid:26919353
Graziano S et al. The global effect of exposing bakers' yeast to 5-fluoruracil and nystatin; a view to Toxichip. 2016 Chemosphere pmid:26694798
Kantarcioglu AS et al. Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples of Children with Suspected or Diagnosed Autism Spectrum Disorders and In Vitro Susceptibility Against Nystatin and Fluconazole. 2016 Mycopathologia pmid:26442855
Kinoshita H et al. Cryptic antifungal compounds active by synergism with polyene antibiotics. 2016 J. Biosci. Bioeng. pmid:26323525
Hashemy SI et al. Oxidative stress factors and C-reactive protein in patients with oral lichen planus before and 2 weeks after treatment. 2016 J. Oral Pathol. Med. pmid:26058710
Marmiroli M et al. A genome-wide nanotoxicology screen of Saccharomyces cerevisiae mutants reveals the basis for cadmium sulphide quantum dot tolerance and sensitivity. 2016 Nanotoxicology pmid:25938282
Pinto Reis C et al. Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment. 2016 Pharm Dev Technol pmid:25567611
Ellepola AN et al. Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates. 2016 J Investig Clin Dent pmid:25388637
Ellepola AN et al. Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans. 2015 Jul-Aug J Appl Oral Sci pmid:26398514
Jakab Á et al. Betamethasone augments the antifungal effect of menadione--towards a novel anti-Candida albicans combination therapy. 2015 J. Basic Microbiol. pmid:25707543
Wittekamp BH et al. Nystatin versus amphotericin B to prevent and eradicate Candida colonization during selective digestive tract decontamination in critically ill patients. 2015 Intensive Care Med pmid:26459880
Dewan E et al. Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India. 2015 Hematol Oncol Stem Cell Ther pmid:26173033
de Castro RD et al. Use of alcohol vinegar in the inhibition of Candida spp. and its effect on the physical properties of acrylic resins. 2015 BMC Oral Health pmid:25928798
Kim HJ et al. Post-PKS tailoring steps of a disaccharide-containing polyene NPP in Pseudonocardia autotrophica. 2015 PLoS ONE pmid:25849545
Park JB et al. Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology. 2015 Expert Opin Drug Deliv pmid:25169007
Malik A et al. Stimulation of erythrocyte cell membrane scrambling by nystatin. 2015 Basic Clin. Pharmacol. Toxicol. pmid:24894380
Chen Y et al. Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration. 2015 Int. J. Cancer pmid:24798787
Sasek V Consequences of Misnomer or Mistakes in Identification of Fungal Species. 2015 Int J Med Mushrooms pmid:26853957
Guerra CM et al. Duration of prophylaxis against fungal infection in kidney transplant recipients. 2015 Prog Transplant pmid:26645924
Austin N et al. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. 2015 Cochrane Database Syst Rev pmid:26497202
Tamura M et al. Involvement of an intracellular vesicular transport process in naked-sgRNA-mediated TRUE gene silencing. 2015 Mol Med Rep pmid:26238202
Boros-Majewska J et al. A novel in vitro assay for assessing efficacy and toxicity of antifungals using human leukaemic cells infected with Candida albicans. 2015 J. Appl. Microbiol. pmid:25845720
Trindade LA et al. Inhibition of adherence of C. albicans to dental implants and cover screws by Cymbopogon nardus essential oil and citronellal. 2015 Clin Oral Investig pmid:25804885
Farrag HA et al. Microbial colonization of irradiated pathogenic yeast to catheter surfaces: Relationship between adherence, cell surface hydrophobicity, biofilm formation and antifungal susceptibility. A scanning electron microscope analysis. 2015 Int. J. Radiat. Biol. pmid:25758055
Korany MA et al. Application of derivative spectrophotometry under orthogonal polynomial at unequal intervals: determination of metronidazole and nystatin in their pharmaceutical mixture. 2015 Spectrochim Acta A Mol Biomol Spectrosc pmid:25748283
Schulz JC et al. Unfolding and folding internal friction of β-hairpins is smaller than that of α-helices. 2015 J Phys Chem B pmid:25741584
Wang MM et al. Mutagenicity of ZnO nanoparticles in mammalian cells: Role of physicochemical transformations under the aging process. 2015 Nanotoxicology pmid:25676621
Yao JY et al. Evaluation of nystatin isolated from Streptomyces griseus SDX-4 against the ciliate, Ichthyophthirius multifiliis. 2015 Parasitol. Res. pmid:25645004
Moriyama T et al. Caveolae may enable albumin to enter human renal glomerular endothelial cells. 2015 J. Cell. Biochem. pmid:25640083
Semis R et al. Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods. 2015 J Mycol Med pmid:25639922
Martín MJ et al. Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery. 2015 Carbohydr Polym pmid:25498619
Fan S et al. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. 2015 Mycopathologia pmid:25416649
Zhu Y et al. Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis. 2015 Mycopathologia pmid:25322705
Oncel MY et al. Comparison of Lactobacillus reuteri and nystatin prophylaxis on Candida colonization and infection in very low birth weight infants. 2015 J. Matern. Fetal. Neonatal. Med. pmid:25245226
Chulkov EG et al. Membrane dipole modifiers modulate single-length nystatin channels via reducing elastic stress in the vicinity of the lipid mouth of a pore. 2015 Biochim. Biophys. Acta pmid:25223717
Kandile NG and Zaky HT New pyrano[2,3-c]pyridazine derivatives with antimicrobial activity synthesized using piperidine as the organocatalyst. 2015 J Enzyme Inhib Med Chem pmid:24666292
Bueno MG et al. Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm. 2015 Oral Dis pmid:24219354